
Sign up to save your podcasts
Or


Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.
By Cleveland Clinic Taussig Cancer Institute5
2424 ratings
Joseph Skitzki, MD, Director of Melanoma and Cutaneous Oncology Surgery at Cleveland Clinic, joins the Cancer Advances podcast to discuss how neoadjuvant immunotherapy is transforming melanoma treatment. Listen as Dr. Skitzki explains how this approach is improving survival and reducing the need for extensive surgery.

43,721 Listeners

141 Listeners

321 Listeners

558 Listeners

2,056 Listeners

501 Listeners

290 Listeners

3,364 Listeners

9,170 Listeners

91 Listeners

362 Listeners

255 Listeners

20,077 Listeners

65 Listeners

190 Listeners